-
Je něco špatně v tomto záznamu ?
Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects
Polak J, Moro C, Klimcakova E, Hejnova J, Majercik M, Viguerie N, Langin D, Lafontan M, Stich V, Berlan M.
Jazyk angličtina Země Německo
Typ dokumentu klinické zkoušky
Grantová podpora
NR8066
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
SpringerLink Journals
od 1997-01-01 do 2012-08-31
ProQuest Central
od 1999-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1999-01-01 do Před 1 rokem
Public Health Database (ProQuest)
od 1999-01-01 do Před 1 rokem
- MeSH
- adrenalin fyziologie MeSH
- alfa-2-adrenergní receptory - antagonisté MeSH
- alfa-2-adrenergní receptory genetika metabolismus MeSH
- antagonisté beta-2-adrenergních receptorů MeSH
- beta-2-adrenergní receptory genetika metabolismus MeSH
- cyklické nukleotidfosfodiesterasy, typ 3 MeSH
- dospělí MeSH
- fentolamin farmakologie MeSH
- financování organizované MeSH
- glycerol analýza chemie MeSH
- glykemický clamp MeSH
- inzulin fyziologie MeSH
- inzulinová rezistence fyziologie MeSH
- isoprenalin farmakologie MeSH
- kyseliny mastné neesterifikované krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- lipolýza MeSH
- messenger RNA analýza MeSH
- metabolismus lipidů MeSH
- obezita metabolismus patofyziologie MeSH
- podkožní břišní tuk chemie metabolismus MeSH
- sterolesterasa fyziologie genetika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- klinické zkoušky MeSH
AIMS/HYPOTHESIS: The aim of this study was to investigate whether dynamic strength training modifies the control of lipolysis, with particular attention paid to the involvement of the antilipolytic adrenergic alpha 2A receptor (ADRA2A) pathway. METHODS: Twelve obese men (age: 47.4+/-2.8 years; BMI: 32.7+/-0.9) were investigated during a 210-min euglycaemic-hyperinsulinaemic clamp conducted before and after 3 months of dynamic strength training. Before and during the third hour of the clamp, the lipolytic effect of a perfusion of isoproterenol or adrenaline (epinephrine) alone or associated with the ADRA2A antagonist phentolamine was evaluated using the microdialysis method of measuring extracellular glycerol concentration (EGC) in subcutaneous abdominal adipose tissue (SCAAT). In addition, biopsies of SCAAT were carried out before and after training to determine mRNA levels RESULTS: The training increased insulin sensitivity in adipose tissue. The decrease of EGC was more pronounced during the clamp conducted after the training period than during the clamp done in pre-training conditions. Before and after the training, catecholamines induced an increase in EGC, the increase being lower during the clamp on each occasion. The isoproterenol-induced increase in EGC was higher after the training. Adrenaline-induced lipolysis was potentiated by phentolamine after but not before the training. There were no training-induced changes in mRNA levels of key genes of the lipolytic pathway in SCAAT. CONCLUSIONS/INTERPRETATION: In obese subjects, dynamic strength training improves whole-body and adipose tissue insulin responsiveness. It increases responsiveness to the adrenergic beta receptor stimulation of lipolysis and to the antilipolytic action of catecholamines mediated by ADRA2As.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07520232
- 003
- CZ-PrNML
- 005
- 20130812125506.0
- 008
- 090330s2005 gw e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Polák, Jan $7 xx0102455
- 245 10
- $a Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects / $c Polak J, Moro C, Klimcakova E, Hejnova J, Majercik M, Viguerie N, Langin D, Lafontan M, Stich V, Berlan M.
- 314 __
- $a Franco-Czech Laboratory for Clinical Research on Obesity, French Institute of Health and Medical Research (Inserm U586) and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
- 520 9_
- $a AIMS/HYPOTHESIS: The aim of this study was to investigate whether dynamic strength training modifies the control of lipolysis, with particular attention paid to the involvement of the antilipolytic adrenergic alpha 2A receptor (ADRA2A) pathway. METHODS: Twelve obese men (age: 47.4+/-2.8 years; BMI: 32.7+/-0.9) were investigated during a 210-min euglycaemic-hyperinsulinaemic clamp conducted before and after 3 months of dynamic strength training. Before and during the third hour of the clamp, the lipolytic effect of a perfusion of isoproterenol or adrenaline (epinephrine) alone or associated with the ADRA2A antagonist phentolamine was evaluated using the microdialysis method of measuring extracellular glycerol concentration (EGC) in subcutaneous abdominal adipose tissue (SCAAT). In addition, biopsies of SCAAT were carried out before and after training to determine mRNA levels RESULTS: The training increased insulin sensitivity in adipose tissue. The decrease of EGC was more pronounced during the clamp conducted after the training period than during the clamp done in pre-training conditions. Before and after the training, catecholamines induced an increase in EGC, the increase being lower during the clamp on each occasion. The isoproterenol-induced increase in EGC was higher after the training. Adrenaline-induced lipolysis was potentiated by phentolamine after but not before the training. There were no training-induced changes in mRNA levels of key genes of the lipolytic pathway in SCAAT. CONCLUSIONS/INTERPRETATION: In obese subjects, dynamic strength training improves whole-body and adipose tissue insulin responsiveness. It increases responsiveness to the adrenergic beta receptor stimulation of lipolysis and to the antilipolytic action of catecholamines mediated by ADRA2As.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a cyklické nukleotidfosfodiesterasy, typ 3 $7 D054684
- 650 _2
- $a adrenalin $x fyziologie $7 D004837
- 650 _2
- $a kyseliny mastné neesterifikované $x krev $7 D005230
- 650 _2
- $a glykemický clamp $7 D015309
- 650 _2
- $a glycerol $x analýza $x chemie $7 D005990
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulin $x fyziologie $7 D007328
- 650 _2
- $a inzulinová rezistence $x fyziologie $7 D007333
- 650 _2
- $a isoprenalin $x farmakologie $7 D007545
- 650 _2
- $a metabolismus lipidů $7 D050356
- 650 _2
- $a lipolýza $7 D008066
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a obezita $x metabolismus $x patofyziologie $7 D009765
- 650 _2
- $a fentolamin $x farmakologie $7 D010646
- 650 _2
- $a messenger RNA $x analýza $7 D012333
- 650 _2
- $a alfa-2-adrenergní receptory $x genetika $x metabolismus $7 D018341
- 650 _2
- $a beta-2-adrenergní receptory $x genetika $x metabolismus $7 D018343
- 650 _2
- $a sterolesterasa $x fyziologie $x genetika $7 D002787
- 650 _2
- $a podkožní břišní tuk $x chemie $x metabolismus $7 D050507
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a alfa-2-adrenergní receptory - antagonisté $7 D058669
- 650 _2
- $a antagonisté beta-2-adrenergních receptorů $7 D058672
- 655 _2
- $a klinické zkoušky $7 D016430
- 700 1_
- $a Moro, C.
- 700 1_
- $a Klimčáková, Eva $7 xx0081734
- 700 1_
- $a Hejnová, Jindra, $d 1947- $7 nlk20040147074
- 700 1_
- $a Majerčík, Marek $7 xx0063148
- 700 1_
- $a Viguerie, N.
- 700 1_
- $a Langin, D.
- 700 1_
- $a Lafontan, M.
- 700 1_
- $a Štich, Vladimír, $d 1946- $7 xx0050390
- 700 1_
- $a Berlan, M.
- 773 0_
- $w MED00001391 $t Diabetologia $g Roč. 48, č. 12 (2005), s. 2631-2640 $x 0012-186X
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20130812130014 $b ABA008
- 999 __
- $a ok $b bmc $g 638035 $s 490833
- BAS __
- $a 3
- BMC __
- $a 2005 $b 48 $c 12 $d 2631-2640 $i 0012-186X $m Diabetologia (Berlin) $x MED00001391
- GRA __
- $a NR8066 $p MZ0
- LZP __
- $a 2009-B2/ipme